MN-201 - CAS 187935-17-7
Catalog number:
187935-17-7
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Description:
MN-201 is an orally administered vitamin D5 analog for the treatment of cancer. MN-201 is the first synthetic vitamin D5 receptor ligand (VDRL) to be advanced into clinical trials for a variety of cancers including breast, prostate and colon cancers. In preclinical studies, MN-201 demonstrated broad anti-tumor activity in cancer cells. In animal models, oral administration of MN-201 also resulted in anti-tumor activity including tumor regression in xenograft models of major solid tumor types. In contrast to treatment with other vitamin D(3) analogs and the naturally occurring vitamin D hormone, calcitriol, favorable anticancer effects with MN-201 were observed in the absence of significantly raised calcium levels.
Publictions citing BOC Sciences Products
  • >> More
Synonyms:
1-alpha hydroxy vitamin D5; CCRIS 8700; LS-144738
MSDS:
Inquire
Current Developer:
Marillion Pharmaceuticals, Inc.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Chemical Structure

CAS 187935-17-7 MN-201

Quick Inquiry

Verification code

Featured Items